Teneriffe

This research aims to evaluate the safety and tolerability of two new artificial tear formulations in adults with moderate dry eye disease. The study includes participants who experience dry eye symptoms and already use artificial tears. It is designed to better understand how these new eye lubricants are tolerated and their safety profile. Participants will receive two investigational eye drop products, one drop per eye of each formulation, in a cross-over design following a randomization schedule. Each participant will use both products during the study period. The total participation will last about 21 days, during which the effects of the two artificial tear formulations will be compared. Throughout the study, participants will attend visits including a screening and exit visit scheduled based on observed visit windows. Researchers will monitor the number of treatment-emergent adverse events, assess eye health through biomicroscopy, and measure best corrected visual acuity. These evaluations will take place from screening through the exit visit to ensure safety and tolerability of the treatments.